Reported cancer screening practices of nephrologists: Results from a national survey

Nephrology Dialysis Transplantation

Volumn 24, Issue 7, 2009, Pages 2136-2143

  Wong, Germaine ^a   Webster, Angela C ^a,b   Chapman, Jeremy R ^c   Craig, Jonathan C ^a,b  

^a CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c WESTMEAD HOSPITAL   (Australia)

Author keywords

Cancer; Screening; Survey

Indexed keywords

ADULT; AGED; ARTICLE; AUSTRALIA; BREAST CANCER; BREAST SELF EXAMINATION; CANCER MORTALITY; CANCER SCREENING; CHRONIC KIDNEY DISEASE; COLORECTAL CANCER; FEMALE; HUMAN; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MAMMOGRAPHY; NEPHROLOGIST; NEW ZEALAND; OCCULT BLOOD; PREVALENCE; PRIORITY JOURNAL; QUESTIONNAIRE; RENAL REPLACEMENT THERAPY; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CHRONIC DISEASE; FEMALE; HUMANS; KIDNEY DISEASES; MALE; MASS SCREENING; MIDDLE AGED; NEOPLASMS; NEPHROLOGY; PHYSICIAN'S PRACTICE PATTERNS; QUESTIONNAIRES;

EID: 67651121920     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp009     Document Type: Article

References (35)

1. Vajdic CM, McDonald SP, McCredie MR et al. Cancer incidence before and after kidney transplantation. JAMA 2006; 296: 2823-2831
2. Brunner FP, Landais P, Selwood NH. European Dialysis and Transplantation Association-European Renal Association. Malignancies after renal transplantation: the EDTA-ERA registry experience. Nephrol Dial Transplant 1995; 10(Suppl 80): 74-80
3. Adami J, Gabel H, Lindelof B et al. Cancer risk following organ transplantation: a nationwide cohort study in Sweden. Br J Cancer 2003; 89: 1221-1227
4. Birkeland SA, Lokkegaard H, Storm HH. Cancer risk in patients on dialysis and after renal transplantation. Lancet 2000; 355: 1886-1887
5. Grulich AE, van Leeuwen MT, Falster MO et al. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 2007; 370: 59-67
6. Kyllonen L, Salmela K, Pukkala E. Cancer incidence in a kidney-transplanted population. Transpl Int 2000; 13(Suppl 8): 394-398
7. Australia and New Zealand dialysis and Transplant Registry. The twenty eighth report, 2005, 132-139
8. Towler B, Irwig L, Glasziou P et al. A systematic review of the effects of screening for colorectal cancer using the faecal occult blood test, hemoccult. BMJ 1998; 317: 559-565
9. Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev 2006; CD001877 Issue 4
10. LeBrun CJ, Diehl LF, Abbott KC et al. Life expectancy benefits of cancer screening in the end-stage renal disease population [see comment]. Am J Kidney Dis 2000; 35: 237-243
11. Kiberd BA, Keough-Ryan T, Clase CM. Screening for prostate, breast and colorectal cancer in renal transplant recipients. Am J Transplant 2003; 3: 619-625
12. Chertow GM, Paltiel AD, Owen WF Jr et al. Cost-effectiveness of cancer screening in end-stage renal disease. Arch Intern Med 1996; 156: 1345-1350
13. Holley JL. Preventive medical screening is not appropriate for many chronic dialysis patients. Semin Dial 2000; 13: 369-371
14. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.1. Cancer risk after renal transplantation. Post-transplant lymphoproliferative disease (PTLD): prevention and treatment. Nephrol Dial Transplant 2002; 17 (Suppl 6): 31
15. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.3. Cancer risk after renal transplantation. Solid organ cancers: prevention and treatment. Nephrol Dial Transplant 2002; 17(Suppl 6): 33-36
16. EBPG Expert Group on Renal Transplantation. European best practice guidelines for renal transplantation. Section IV: long-term management of the transplant recipient. IV.6.2. Cancer risk after renal transplantation. Skin cancers: prevention and treatment. Nephrol Dial Transplant 2002; 17(Suppl 6): 31-32
17. Kasiske BL, Vazquez MA, Harmon WE et al. American Society of Transplantation. Recommendations for the outpatient surveillance of renal transplant recipients. JASN 2000; 11(suppl 8): S1-S86
18. Zarychanski R, Chen Y, Bernstein CN et al. Frequency of colorectal cancer screening and the impact of family physicians on screening behaviour. CMAJ 2007; 177: 593-597
19. Timonen S, Pyorala T. Cervical cancer. Mass screening, incidence and mortality in Finland. Acta Obstet Gynecol Scand Suppl 1977; 67: 13-19
20. Walker JJ, Brewster D, Gould A et al. Trends in incidence of and mortality from invasive cancer of the uterine cervix in Scotland (1975-1994). Public Health 1998; 112: 373-378
21. Barratt A, Irwig L, Glasziou P et al. Evidence-Based Medicine Working Group. Users' guides to the medical literature: XVII. How to use guidelines and recommendations about screening. JAMA 1999; 281: 2029-2034
22. Webster AC, Craig JC, Simpson JM et al. Identifying high risk groups and quantifying absolute risk of cancer after kidney transplantation: a cohort study of 15,183 recipients. Am J Transplant 2007; 7: 2140-2151
23. Walter LC, Lindquist K, O'Hare AM et al. Targeting screening mammography according to life expectancy among women undergoing dialysis. Arch Intern Med 2006; 166: 1203-1208
24. Kosters JP, Gotzsche PC. Regular self-examination or clinical examination for early detection of breast cancer [see comment] [Review] [24 refs]. Cochrane Database Syst Rev 2003; (Issue 2) CD003373
25. The Australian Institute of Health and Welfare and the Australian Government Department of Health and Ageing for the BreastScreen Australia Program. BreastScreen Australia Monitoring Report 2001-2002, 2003
26. Canfell K, Sitas F, Beral V. Cervical cancer in Australia and the United Kingdom: comparison of screening policy and uptake, and cancer incidence and mortality [see comment]. Med J Aust 2006; 185: 482-486
27. Chapman S, McLeod K, Wakefield M et al. Impact of news of celebrity illness on breast cancer screening: Kylie Minogue's breast cancer diagnosis. Med J Aust 2005; 183: 247-250
28. Lane DS, Polednak AP, Burg MA. The impact of media coverage of Nancy Reagan's experience on breast cancer screening. Am J Public Health 1989; 79: 1551-1552
29. Chan EC, Vernon SW, Haynes MC et al. Physician perspectives on the importance of facts men ought to know about prostate-specific antigen testing [see comment]. J Gen Intern Med 2003; 18: 350-356
30. Nguyen TT, Gildengorin G, Truong A et al. Factors influencing physicians' screening behavior for liver cancer among high-risk patients. J Gen Intern Med 2007; 22: 523-526
31. Ward J, Young J, Sladden M. Australian general practitioners' views and use of tests to detect early prostate cancer. Aust NZ J Public Health 1998; 22(Suppl 80): S374-380
32. Montano DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health 1995; 85: 795-800
33. Cochrane AL, Holland WW. Validation of screening procedures [Review] [37 refs]. Br Med Bull 1971; 27: 3-8
34. Obuchowski NA, Graham RJ, Baker ME et al. Ten criteria for effective screening: their application to multislice CT screening for pulmonary and colorectal cancers [see comment] [Review] [49 refs]. AJR Am J Roentgenol 2001; 176: 1357-1362
35. Wong G, Howard K, Craig JC et al. Cost-effectiveness of colorectal cancer screening in renal transplant recipients. Transplantation 2008; 85: 532-541